Mpact Cup Performance After Total Hip Arthroplasty

Last updated: September 23, 2025
Sponsor: Medacta International SA
Overall Status: Suspended

Phase

N/A

Condition

Hip Replacement

Treatment

N/A

Clinical Study ID

NCT02846636
P01.014.07
  • Ages > 18
  • All Genders

Study Summary

The main objective of this study is to evaluate the 10 year performances of Mpact cup in total hip arthroplasty.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • patients requiring a total hip replacement who meets the standard indications foruse for Medacta implants

  • patients who accept to participate in the study

  • patients who signed the consent form for the treatment of personal data

Exclusion

Exclusion Criteria:

  • patients presenting conditions identified as contraindication for Medacta implants

  • revision surgeries

Study Design

Total Participants: 100
Study Start date:
August 01, 2014
Estimated Completion Date:
April 30, 2029

Connect with a study center

  • Clinique Médico-Chirurgicale Paris V

    Paris 2988507, France 75007
    France

    Site Not Available

  • Clinique Médico-Chirurgicale Paris V

    Paris, 75007
    France

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.